InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Yelensky Roman, Dirigeant. Director active across 1 companies, notably Gritstone bio, Inc.. Aggregated, 6 filings have been published. Total volume traded: €366k. The latest transaction was disclosed on 8 March 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€183,01210,000 shares@ €18.301285.0% of flow
Common Stock
SEC:0001567619-21-020893·
027,400 shares0
Common Stock
SEC:0001567619-21-020876·
€32,28350,724 shares@ €0.636415.0% of flow
Common Stock
SEC:0001567619-21-020894·
€183,01210,000 shares@ €18.301242.5% of flow
Common Stock
SEC:0001567619-21-020893:0·
027,400 shares0
Common Stock
SEC:0001567619-21-020876:0·
€32,28350,724 shares@ €0.63647.5% of flow
Common Stock
SEC:0001567619-21-020894:0·
6 of 6 declarations
About Yelensky Roman
Roman Yelensky is an executive at Gritstone bio, Inc. While his role is not specified, he is involved in the company's leadership, which focuses on developing immunotherapeutic treatments. Roman contributes to Gritstone's mission of transforming healthcare through innovation.
